Literature DB >> 27342010

Neonatal kaposiform hemangioendothelioma of the spleen associated with Kasabach-Merritt phenomenon.

Samuel A Shabtaie1, Bo Wang1, Mark Owyong1, Catalina Ruiz-Mesa2, Fernando F Corrales-Medina2, Claudia P Rojas3, Juan C Infante4, Holly L Neville1, Eduardo A Perez1, Juan E Sola1, Anthony R Hogan5.   

Abstract

Kaposiform hemangioendothelioma is a rare locally aggressive vascular tumor that usually manifests during early childhood. Typically the lesion presents with skin, soft tissue and bone involvement and is characterized histologically by ill-defined nodularity and the presence of spindle cells with resemblance to Kaposi's sarcoma. We report a rare neonatal case of a splenic kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon that was diagnosed with radiographic imaging. Because of the rapid onset of thrombocytopenia and anemia, the patient required urgent splenectomy with subsequent resolution of the blood dyscrasias.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Kaposiform hemangioendothelioma; Kasabach-Merritt phenomenon; Neonatal kaposiform hemangioendothelioma; Splenic mass; Vascular tumor

Mesh:

Year:  2016        PMID: 27342010     DOI: 10.1016/j.jpedsurg.2016.03.014

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  2 in total

1.  Health-Related Quality of Life in Children With Kaposiform Hemangioendothelioma.

Authors:  Shiyi Dai; Kaiying Yang; Tong Qiu; Jiangyuan Zhou; Xuepeng Zhang; Siyuan Chen; Lizhi Li; Yi Ji
Journal:  Front Pediatr       Date:  2022-02-24       Impact factor: 3.418

2.  Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature.

Authors:  Matteo Chinello; Daniela Di Carlo; Francesca Olivieri; Rita Balter; Massimiliano De Bortoli; Virginia Vitale; Ada Zaccaron; Elisa Bonetti; Alice Parisi; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.